ArticleJournal of diabetes research2019
Prevalence, Awareness, Treatment, Control, and the Associated Factors of Diabetes in an Iranian Kurdish Population.
Article in Journal of diabetes research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
29 citing papers in PubMed, 1 synthesis or guideline pooled it.
- The worldwide trend in diabetes awareness, treatment, and control from 1985 to 2022: a systematic review and meta-analysis of 233 population-representative studies.Frontiers in public health · 2024Pooled it
- Article
- Article
- The relationship of dietary omega-3 fatty acid and omega-6 to omega-3 ratio intake and likelihood of type 2 diabetes in a cross-sectional study.BMC endocrine disorders · 2024Article
- Article
- International dietary quality index and its association with diabetes in RaNCD cohort study.Scientific reports · 2024Article
- Optimizing antidiabetic properties ofFood science & nutrition · 2024Article
- Dietary amino acid profile and risk of hypertension: findings from the Ravansar cohort study.BMC nutrition · 2024Article
- The Burden of Type 2 Diabetes Mellitus and Attributable Risk Factors in Iran, 1990-2019: Results from the Global Burden of Disease Study 2019.Iranian journal of public health · 2024Article
- Trends in diabetes prevalence, awareness, treatment, and control in French-speaking Switzerland.Scientific reports · 2024Article
- Socioeconomic disparities in Papanicolaou test utilization in Western Iran.BMC public health · 2024Article
- Awareness of Hypertension, Hypercholesterolemia, and Diabetes Mellitus and Associated Characteristics in Russian Adults.International journal of hypertension · 2024Article
- Role of remnant cholesterol in the relationship between physical activity and diabetes mellitus: an intermediary analysis.Frontiers in public health · 2024Article
- Article
- The association between dietary amino acid profile and the risk of type 2 diabetes: Ravansar non-communicable disease cohort study.BMC public health · 2023Article
- Awareness of the diagnosis, treatment, and control of diabetes mellitus in Brazil.Revista de saude publica · 2023Article
- Estimation of type 2 diabetes risk score using diabetes risk test in Neishabour-Iran.Journal of education and health promotion · 2023Article
- Prevalence, awareness, treatment, and control of type 2 diabetes mellitus among the adult residents of tehran: Tehran Cohort Study.BMC endocrine disorders · 2022Article
- Pre-diabetes, Diabetes Mellitus and Related Cardio-metabolic Risk Factors in the Southern Coastal Region of Iran Middle-aged and Elderly Population; Bandare-Kong Cohort Study.Archives of Iranian medicine · 2022Article
- Metabolic obesity phenotypes and chronic kidney disease: a cross-sectional study from the RaNCD cohort study.BMC nephrology · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
aimsThis study is aimed at estimating the prevalence, awareness, treatment, and glycemic control of diabetes mellitus (DM) and its associated factors in an Iranian Kurdish population.
methodsBaseline data of the Ravansar Non-communicable Disease (RaNCD) cohort study, consisting of adults aged 35-65 years, were used. Diabetes was defined as a fasting plasma glucose (FPG) of 126 mg/dl or higher, being on diabetes medication, and/or diabetes confirmed by a health practitioner.
resultsNine thousand nine hundred ninety-nine participants were assigned to this study. The prevalence of DM, awareness, treatment, and glycemic control of DM were 8.19, 74.97, 74.75, and 32.68, respectively. Based on the adjusted models, increased age (
conclusionsWhen the prevalence of DM is notable, awareness and probability of receiving treatment and controlling FPG are of particular importance. A considerable proportion of the patients were aware and on treatment, which may partly be due to improving primary health care services in Iran.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.